Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HH93
Term | Name | Level | Count |
---|---|---|---|
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003677 | DNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0000182 | rDNA binding | 7 | 1 |
GO:0000217 | DNA secondary structure binding | 5 | 1 |
GO:0000400 | four-way junction DNA binding | 6 | 1 |
GO:0000402 | crossed form four-way junction DNA binding | 7 | 1 |
GO:0003690 | double-stranded DNA binding | 5 | 1 |
GO:0008301 | DNA binding, bending | 5 | 1 |
GO:0043565 | sequence-specific DNA binding | 5 | 1 |
GO:1990837 | sequence-specific double-stranded DNA binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 286 | 290 | PF00656 | 0.698 |
CLV_C14_Caspase3-7 | 291 | 295 | PF00656 | 0.702 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.301 |
CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.597 |
CLV_PCSK_FUR_1 | 84 | 88 | PF00082 | 0.703 |
CLV_PCSK_KEX2_1 | 103 | 105 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.216 |
CLV_PCSK_KEX2_1 | 261 | 263 | PF00082 | 0.303 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.300 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.552 |
CLV_PCSK_PC1ET2_1 | 103 | 105 | PF00082 | 0.525 |
CLV_PCSK_PC1ET2_1 | 190 | 192 | PF00082 | 0.559 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.216 |
CLV_PCSK_PC1ET2_1 | 261 | 263 | PF00082 | 0.303 |
CLV_PCSK_PC1ET2_1 | 86 | 88 | PF00082 | 0.569 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.295 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 194 | 198 | PF00082 | 0.655 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.196 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.462 |
DEG_SPOP_SBC_1 | 283 | 287 | PF00917 | 0.733 |
DEG_SPOP_SBC_1 | 288 | 292 | PF00917 | 0.741 |
DOC_CKS1_1 | 61 | 66 | PF01111 | 0.555 |
DOC_MAPK_MEF2A_6 | 115 | 124 | PF00069 | 0.498 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.407 |
DOC_USP7_MATH_1 | 269 | 273 | PF00917 | 0.586 |
DOC_USP7_MATH_1 | 283 | 287 | PF00917 | 0.642 |
DOC_USP7_MATH_1 | 288 | 292 | PF00917 | 0.751 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.461 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.622 |
DOC_USP7_UBL2_3 | 103 | 107 | PF12436 | 0.547 |
DOC_USP7_UBL2_3 | 190 | 194 | PF12436 | 0.533 |
DOC_USP7_UBL2_3 | 96 | 100 | PF12436 | 0.677 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.498 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.585 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.458 |
LIG_14-3-3_CanoR_1 | 209 | 217 | PF00244 | 0.431 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.554 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.442 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.559 |
LIG_FHA_1 | 61 | 67 | PF00498 | 0.514 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.582 |
LIG_LIR_Gen_1 | 119 | 125 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 161 | 170 | PF02991 | 0.535 |
LIG_LIR_Nem_3 | 119 | 124 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 161 | 166 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 212 | 217 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 45 | 49 | PF02991 | 0.578 |
LIG_RPA_C_Fungi | 179 | 191 | PF08784 | 0.466 |
LIG_SH2_CRK | 163 | 167 | PF00017 | 0.300 |
LIG_SH2_STAP1 | 174 | 178 | PF00017 | 0.331 |
LIG_SH2_STAP1 | 252 | 256 | PF00017 | 0.266 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.281 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.529 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.281 |
LIG_SH3_2 | 204 | 209 | PF14604 | 0.578 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.579 |
LIG_SH3_3 | 271 | 277 | PF00018 | 0.577 |
LIG_SUMO_SIM_anti_2 | 16 | 23 | PF11976 | 0.418 |
LIG_TRAF2_1 | 251 | 254 | PF00917 | 0.417 |
LIG_UBA3_1 | 144 | 153 | PF00899 | 0.300 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.325 |
MOD_CK1_1 | 272 | 278 | PF00069 | 0.631 |
MOD_CK1_1 | 282 | 288 | PF00069 | 0.731 |
MOD_CK1_1 | 290 | 296 | PF00069 | 0.658 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.633 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.341 |
MOD_CK2_1 | 153 | 159 | PF00069 | 0.411 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.369 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.535 |
MOD_Cter_Amidation | 192 | 195 | PF01082 | 0.574 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.622 |
MOD_GlcNHglycan | 244 | 247 | PF01048 | 0.489 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.808 |
MOD_GlcNHglycan | 286 | 289 | PF01048 | 0.725 |
MOD_GlcNHglycan | 78 | 83 | PF01048 | 0.522 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.510 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.257 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.685 |
MOD_GSK3_1 | 283 | 290 | PF00069 | 0.648 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.533 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.624 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.537 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.411 |
MOD_PKA_1 | 153 | 159 | PF00069 | 0.331 |
MOD_PKA_2 | 269 | 275 | PF00069 | 0.530 |
MOD_PKA_2 | 82 | 88 | PF00069 | 0.538 |
MOD_PKB_1 | 87 | 95 | PF00069 | 0.698 |
MOD_Plk_1 | 13 | 19 | PF00069 | 0.348 |
MOD_Plk_1 | 158 | 164 | PF00069 | 0.331 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.352 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.360 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.481 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.451 |
MOD_SUMO_rev_2 | 167 | 172 | PF00179 | 0.260 |
MOD_SUMO_rev_2 | 201 | 207 | PF00179 | 0.472 |
MOD_SUMO_rev_2 | 245 | 251 | PF00179 | 0.331 |
TRG_DiLeu_BaEn_1 | 52 | 57 | PF01217 | 0.331 |
TRG_ENDOCYTIC_2 | 121 | 124 | PF00928 | 0.281 |
TRG_ENDOCYTIC_2 | 163 | 166 | PF00928 | 0.281 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.281 |
TRG_ENDOCYTIC_2 | 252 | 255 | PF00928 | 0.281 |
TRG_ER_diArg_1 | 34 | 37 | PF00400 | 0.281 |
TRG_NLS_MonoExtN_4 | 191 | 198 | PF00514 | 0.671 |
TRG_NLS_MonoExtN_4 | 83 | 90 | PF00514 | 0.493 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8C9 | Leptomonas seymouri | 64% | 99% |
A0A0S4KNH5 | Bodo saltans | 37% | 77% |
A0A1X0NZM0 | Trypanosomatidae | 45% | 100% |
A0A3Q8IEB8 | Leishmania donovani | 86% | 99% |
A0A3R7KR63 | Trypanosoma rangeli | 46% | 100% |
A4I4D9 | Leishmania infantum | 86% | 99% |
C9ZL24 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9ADT8 | Leishmania major | 87% | 100% |
E9ALZ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
P26586 | Trypanosoma brucei rhodesiense | 43% | 100% |
V5B1M8 | Trypanosoma cruzi | 49% | 100% |